Karl Goodkin, MD, PhD is Director of Clinical Research in the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai. Before joining Cedars-Sinai, he was professor of Psychiatry and Behavioral Sciences and Neurology in the Miller School of Medicine at the University of Miami.
Dr. Goodkin serves as Chairman for the State of Florida's Physicians' Advisory Board to the U.S. Congress. He has been a member of the Committee on AIDS of the American Psychiatric Association since 1992 and was a member of its original Work Group on HIV/AIDS Practice Guidelines, which were published in the American Journal of Psychiatry in 2000.
Dr. Goodkin's research interests concern the causes, treatment and prevention of HIV-1 associated cognitive-motor impairment, specifically in older persons and in Spanish speakers living in the United States and Argentina. He conducts clinical trials of HIV-1 associated cognitive-motor impairment, progressive multifocal leukoencephalopathy and painful peripheral neuropathy. He also has been a collaborator in international studies of psychoneuroimmunology in cervical cancer, HIV/AIDS, malignant melanoma and prostate cancer.
Dr. Goodkin served on the Mental Health, AIDS, and Immunology Review Committee of the National Institute of Mental Health, and has been a member of review committees for National Institute on Aging, National Institute of Neurological Disorders and Stroke, National Institute on Drug Abuse, National Center on Minority Health and Health Disparities and National Institute of Dental Research.
Dr. Goodkin received his bachelor's degree from Williams College in Williamstown, Massachusetts and his medical degree and doctorate from the University of Miami. He then completed a psychiatry residency and a research fellowship at Stanford University.
